Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Russell Middaugh

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Immunohorizons|February 16, 2019
Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal AntibodiesGreta Van Slyke, Siva Krishna Angalakurthi, Ronald T Toth, et al.
Human Vaccines & Immunotherapeutics|April 9, 2013
Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigenJustin C Thomas, Joanne M O'Hara, Lei Hu, et al.
Journal of Pharmaceutical Sciences|March 19, 2016
Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in MiceNewton Wahome, Erin Sully, Christopher Singer, et al.
Human Vaccines & Immunotherapeutics|July 25, 2013
Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasisWeiqiang Cheng, Elena Curti, Wanderson C Rezende, et al.
Proteins|July 19, 2017
Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodiesAndrea Bazzoli, David J Vance, Michael J Rudolph, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2017
High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit VaccineRonald T Toth, Siva Krishna Angalakurthi, Greta Van Slyke, et al.
Protein Science : a Publication of the Protein Society|July 22, 2014
Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometrySubhashchandra Naik, Ozan S Kumru, Melissa Cullom, et al.
Journal of Pharmaceutical Sciences|July 10, 2017
Chemical Stability of the Botanical Drug Substance Crofelemer: A Model System for Comparative Characterization of Complex Mixture DrugsAsha Hewarathna, Olivier Mozziconacci, Maulik K Nariya, et al.
Protein Engineering, Design & Selection : PEDS|September 29, 2018
Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activityMichael J Rudolph, David J Vance, Simon Kelow, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
The Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture DrugsPeter A Kleindl, Jian Xiong, Asha Hewarathna, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Immunohorizons|February 16, 2019
Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal AntibodiesGreta Van Slyke, Siva Krishna Angalakurthi, Ronald T Toth, et al.
Human Vaccines & Immunotherapeutics|April 9, 2013
Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigenJustin C Thomas, Joanne M O'Hara, Lei Hu, et al.
Journal of Pharmaceutical Sciences|March 19, 2016
Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in MiceNewton Wahome, Erin Sully, Christopher Singer, et al.
Human Vaccines & Immunotherapeutics|July 25, 2013
Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasisWeiqiang Cheng, Elena Curti, Wanderson C Rezende, et al.
Proteins|July 19, 2017
Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodiesAndrea Bazzoli, David J Vance, Michael J Rudolph, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2017
High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit VaccineRonald T Toth, Siva Krishna Angalakurthi, Greta Van Slyke, et al.
Protein Science : a Publication of the Protein Society|July 22, 2014
Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometrySubhashchandra Naik, Ozan S Kumru, Melissa Cullom, et al.
Journal of Pharmaceutical Sciences|July 10, 2017
Chemical Stability of the Botanical Drug Substance Crofelemer: A Model System for Comparative Characterization of Complex Mixture DrugsAsha Hewarathna, Olivier Mozziconacci, Maulik K Nariya, et al.
Protein Engineering, Design & Selection : PEDS|September 29, 2018
Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activityMichael J Rudolph, David J Vance, Simon Kelow, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
The Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture DrugsPeter A Kleindl, Jian Xiong, Asha Hewarathna, et al.
Pageof 28